GRAHAM RACHAL: Open Payments
NPI 1225456304 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 97 payments from 21 companies in 2025. Trend: 2023 $1,170 · 2024 $1,461 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $248 |
| ABBVIE INC. | 18 | $214 |
| Lilly USA, LLC | 12 | $213 |
| Novo Nordisk Inc | 12 | $199 |
| GlaxoSmithKline, LLC. | 8 | $137 |
| Dexcom, Inc. | 5 | $114 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Amgen Inc. | 4 | $63 |
Products named: AIRSUPRA, MOUNJARO, JARDIANCE, Dexcom G6 Transmitter, TRELEGY ELLIPTA, INSPIRE, Ozempic, Rybelsus.
Industry payments across LA — which companies pay providers there.
